1. Author reply. Issue 5 (14th May 2013) Authors: Prakoso, E.; Jones, C.; Koorey, D. J.; Strasser, S. I.; Bowen, D.; McCaughan, G. W.; Shackel, N. A. Journal: Internal medicine journal Issue: Volume 43:Issue 5(2013) Page Start: 607 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Lower serum fibroblast activation protein shows promise in the exclusion of clinically significant liver fibrosis due to non-alcoholic fatty liver disease in diabetes and obesity. Issue 3 (June 2015) Authors: Williams, K.H.; Viera de Ribeiro, A.J.; Prakoso, E.; Veillard, A.S.; Shackel, N.A.; Bu, Y.; Brooks, B.; Cavanagh, E.; Raleigh, J.; McLennan, S.V.; McCaughan, G.W.; Bachovchin, W.W.; Keane, F.M.; Zekry, A.; Twigg, S.M.; Gorrell, M.D. Journal: Diabetes research and clinical practice Issue: Volume 108:Issue 3(2015) Page Start: 466 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Terlipressin therapy for moderate‐to‐severe hyponatraemia in patients with liver failure. Issue 3 (27th February 2013) Authors: Prakoso, E.; Jones, C.; Koorey, D. J.; Strasser, S. I.; Bowen, D.; McCaughan, G. W.; Shackel, N. A. Journal: Internal medicine journal Issue: Volume 43:Issue 3(2013) Page Start: 240 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗